(CIDRAP News) A spokesman for Roche, the maker of oseltamivir (Tamiflu), said yesterday that Denmark's report of resistance to the drug in a patient with novel H1N1 (swine) influenza, the first reported finding of its kind, wasn't surprising and that the news underscores the importance of monitoring for any viral changes.